A dose of reality for rational therapies.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017277:Drug Approval / Q000379:methods*; D016503:Drug Delivery Systems / Q000379:methods*; D015195:Drug Design; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012107:Research Design; D014481:United States
D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors